J Remon-Massip

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Background In a significant percentage of advanced non-small-cell lung cancer (NSCLC) patients, tumor tissue is unavailable or insufficient for genetic analyses. We prospectively analyzed if circulating-free DNA (cfDNA) purified from blood can be used as a surrogate in this setting to select patients for treatment with epidermal growth factor receptor(More)
  • 1